A preclinical study demonstrating the efficacy of nilotinib in inhibiting the growth of pediatric high-grade glioma
Crossref DOI link: https://doi.org/10.1007/s11060-015-1744-y
Published Online: 2015-03-04
Published Print: 2015-05
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Au, Karolyn
Singh, Sanjay K.
Burrell, Kelly
Sabha, Nesrin
Hawkins, Cynthia
Huang, Annie
Zadeh, Gelareh
License valid from 2015-03-04